These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11758582

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act.
    Grabowski HG, Kyle M, Mortimer R, Long G, Kirson N.
    Health Aff (Millwood); 2011 Nov; 30(11):2157-66. PubMed ID: 22068409
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Delayed access to generic medicine: a comment on the Hatch-Waxman Act and the "approval bottleneck".
    Patel AN.
    Fordham Law Rev; 2009 Nov; 78(2):1075-115. PubMed ID: 19938382
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA.
    Food Drug Law J; 2000 Nov; 55(3):321-41. PubMed ID: 11824464
    [No Abstract] [Full Text] [Related]

  • 28. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR.
    Suffolk Univ Law Rev; 2003 Nov; 36(3):787-819. PubMed ID: 16493844
    [No Abstract] [Full Text] [Related]

  • 29. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV.
    Food Drug Law J; 2007 Nov; 62(1):249-56. PubMed ID: 17444032
    [No Abstract] [Full Text] [Related]

  • 30. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity.
    Morag-Sela T, Cohn I, Kowalski TJ, Jarecki-Black J, Clyde-Watson Z.
    Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670
    [No Abstract] [Full Text] [Related]

  • 31. The right to a jury trial in actions under the Waxman-Hatch Act.
    Coggio BD, Bresnick SA.
    Food Drug Law J; 1997 Dec; 52(3):259-76. PubMed ID: 10343025
    [No Abstract] [Full Text] [Related]

  • 32. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ.
    Food Drug Law J; 2007 Dec; 62(1):77-137. PubMed ID: 17444027
    [No Abstract] [Full Text] [Related]

  • 33. Staving off death: a case study of the pharmaceutical industry's strategies to protect blockbuster franchises.
    Gorlin DI.
    Food Drug Law J; 2008 Dec; 63(4):823-64. PubMed ID: 19601385
    [No Abstract] [Full Text] [Related]

  • 34. Is Noerr-Pennington immunity still a viable defense against antitrust claims arising from Hatch-Waxman litigation?
    Steinhauer EH.
    Food Drug Law J; 2006 Dec; 61(4):679-700. PubMed ID: 17180769
    [No Abstract] [Full Text] [Related]

  • 35. How Cuozzo will impact the interplay between post grant proceedings and Hatch-Waxman litigation.
    Mishra N, Doody PA, Davé RS.
    Pharm Pat Anal; 2017 Jan; 6(1):9-15. PubMed ID: 28181455
    [No Abstract] [Full Text] [Related]

  • 36. The right to a jury trial under the Waxman-Hatch Act--the question revisited and resolved.
    Coggio BD, DeMasi TE.
    Food Drug Law J; 2002 Jan; 57(1):155-60. PubMed ID: 12118478
    [No Abstract] [Full Text] [Related]

  • 37. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA.
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract] [Full Text] [Related]

  • 38. Biosimilars: impact of differences with Hatch-Waxman.
    Kowalchyk K, Crowley-Weber C.
    Pharm Pat Anal; 2013 Jan; 2(1):29-37. PubMed ID: 24236968
    [Abstract] [Full Text] [Related]

  • 39. Supreme Court rules against drug patent "evergreening".
    Kondro W.
    CMAJ; 2006 Dec 05; 175(12):1508-9. PubMed ID: 17146081
    [No Abstract] [Full Text] [Related]

  • 40. The Hatch-Waxman Act: encouraging innovation and generic drug competition.
    Sokal AM, Gerstenblith BA.
    Curr Top Med Chem; 2010 Dec 05; 10(18):1950-9. PubMed ID: 20615183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.